Vitamin D and Pancreatic Cancer

被引:27
作者
Stolzenberg-Solomon, Rachael Z. [1 ]
机构
[1] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth Human Serv, Rockville, MD USA
基金
美国国家卫生研究院;
关键词
Vitamin D Intake; 25-Hydroxy-Vitamin D Status; Pancreatic Cancer; INSULIN-RECEPTOR GENE; D ANALOGS; SUBSEQUENT RISK; UNITED-STATES; D METABOLITES; MORTALITY; GLUCOSE; 25-HYDROXYVITAMIN-D; METAANALYSIS; POPULATION;
D O I
10.1016/j.annepidem.2008.03.010
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
Sun exposure has been associated with lower death rates for pancreatic cancer in ecological studies. Skin exposure to solar ultraviolet B radiation induces cutaneous production of precursors to 25-hydroxy (OH) vitamin D (D) and is considered the primary contributor to vitamin D status in most Populations. Pancreatic islet and duct cells express 25-(OH) D-3-1 alpha-hydroxylase that generates the biologically active 1,25, dihydroxy(OH), D form. Thus, 25(OH)D concentrations could affect pancreatic function and possibly pancreatic cancer etiology. Serum 25-(OH)D is the major circulating vitamin D metabolite and is considered the best indicator of vitamin D status as determined by the sun and diet. Although recent prospective epidemiologic studies of higher predicted vitamin D status score and vitamin D intake and pancreatic cancer risk suggest protective associations, a nested case,control study showed a significant 3-fold increased risk for pancreatic cancer with higher vitamin D status. Limitations of these Studies include the former do not measure vitamin D status on pancreatic cancer cases and the later was conducted in a male smoker population. More research is needed, particularly examination of pre-diagnostic vitamin D status and risk of pancreatic cancer, prior to conclusions for vitamin D's potential role in the etiology of this highly fatal cancer.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 66 条
[1]
[Anonymous], CANC EPIDEMIOLOGY PR
[2]
BALKAU B, 1993, DIABETES METAB, V19, P458
[3]
Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study [J].
Batty, GD ;
Shipley, MJ ;
Marmot, M ;
Smith, GD .
CANCER CAUSES & CONTROL, 2004, 15 (09) :873-881
[4]
INFLUENCE OF DIABETES ON SUSCEPTIBILITY TO EXPERIMENTAL PANCREATIC-CANCER [J].
BELL, RH ;
MCCULLOUGH, PJ ;
POUR, PM .
AMERICAN JOURNAL OF SURGERY, 1988, 155 (01) :159-164
[5]
A meta-analysis of obesity and the risk of pancreatic cancer [J].
Berrington de Gonzalez, A ;
Sweetland, S ;
Spencer, E .
BRITISH JOURNAL OF CANCER, 2003, 89 (03) :519-523
[6]
Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets [J].
Bland, R ;
Markovic, D ;
Hills, CE ;
Hughes, SV ;
Chan, SLF ;
Squires, PE ;
Hewison, M .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) :121-125
[7]
Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002 [J].
Boscoe, Francis P. ;
Schymura, Maria J. .
BMC CANCER, 2006, 6 (1)
[8]
Calvo MS, 2003, NUTR REV, V61, P107, DOI 10.1301/nr.2003.marr.107-113
[9]
Measurement of vitamin D metabolites: an international perspective on methodology and clinical interpretation [J].
Carter, GD ;
Carter, CR ;
Gunter, E ;
Jones, J ;
Jones, G ;
Makin, HLJ ;
Sufi, S .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) :467-471
[10]
How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme [J].
Carter, GD ;
Carter, R ;
Jones, J ;
Berry, J .
CLINICAL CHEMISTRY, 2004, 50 (11) :2195-2197